The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Respiratory Diagnostics-Global Market Insights and Sales Trends 2024
Synopsis
The global Respiratory Diagnostics market size is expected to reach US$ 7350.7 million by 2029, growing at a CAGR of 4.1% from 2023 to 2029. The market is mainly driven by the significant applications of Respiratory Diagnostics in various end use industries. The expanding demands from the Hospital/Clinical Laboratories, Physician Offices, Reference Laboratories and Other End Users, are propelling Respiratory Diagnostics market. Instruments and Devices, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Assays and Reagents segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Respiratory Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Respiratory Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Respiratory Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Respiratory Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Respiratory Diagnostics covered in this report include Philips Healthcare, Becton, Dickinson, Abbott Laboratories, Thermo Fisher Scientific and Abbott, etc.
The global Respiratory Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Philips Healthcare
Becton, Dickinson
Abbott Laboratories
Thermo Fisher Scientific
Abbott
Global Respiratory Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Respiratory Diagnostics market, Segment by Type:
Instruments and Devices
Assays and Reagents
Services and Software
Global Respiratory Diagnostics market, by Application
Hospital/Clinical Laboratories
Physician Offices
Reference Laboratories
Other End Users
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Respiratory Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Respiratory Diagnostics market size is expected to reach US$ 7350.7 million by 2029, growing at a CAGR of 4.1% from 2023 to 2029. The market is mainly driven by the significant applications of Respiratory Diagnostics in various end use industries. The expanding demands from the Hospital/Clinical Laboratories, Physician Offices, Reference Laboratories and Other End Users, are propelling Respiratory Diagnostics market. Instruments and Devices, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Assays and Reagents segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Respiratory Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Respiratory Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Respiratory Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Respiratory Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Respiratory Diagnostics covered in this report include Philips Healthcare, Becton, Dickinson, Abbott Laboratories, Thermo Fisher Scientific and Abbott, etc.
The global Respiratory Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Philips Healthcare
Becton, Dickinson
Abbott Laboratories
Thermo Fisher Scientific
Abbott
Global Respiratory Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Respiratory Diagnostics market, Segment by Type:
Instruments and Devices
Assays and Reagents
Services and Software
Global Respiratory Diagnostics market, by Application
Hospital/Clinical Laboratories
Physician Offices
Reference Laboratories
Other End Users
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Respiratory Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Respiratory Diagnostics
1.1 Respiratory Diagnostics Market Overview
1.1.1 Respiratory Diagnostics Product Scope
1.1.2 Respiratory Diagnostics Market Status and Outlook
1.2 Global Respiratory Diagnostics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Respiratory Diagnostics Market Size by Region (2018-2029)
1.4 Global Respiratory Diagnostics Historic Market Size by Region (2018-2023)
1.5 Global Respiratory Diagnostics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Respiratory Diagnostics Market Size (2018-2029)
1.6.1 North America Respiratory Diagnostics Market Size (2018-2029)
1.6.2 Europe Respiratory Diagnostics Market Size (2018-2029)
1.6.3 Asia-Pacific Respiratory Diagnostics Market Size (2018-2029)
1.6.4 Latin America Respiratory Diagnostics Market Size (2018-2029)
1.6.5 Middle East & Africa Respiratory Diagnostics Market Size (2018-2029)
2 Respiratory Diagnostics Market by Type
2.1 Introduction
2.1.1 Instruments and Devices
2.1.2 Assays and Reagents
2.1.3 Services and Software
2.2 Global Respiratory Diagnostics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Respiratory Diagnostics Historic Market Size by Type (2018-2023)
2.2.2 Global Respiratory Diagnostics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Respiratory Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Respiratory Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Respiratory Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Respiratory Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Respiratory Diagnostics Revenue Breakdown by Type (2018-2029)
3 Respiratory Diagnostics Market Overview by Application
3.1 Introduction
3.1.1 Hospital/Clinical Laboratories
3.1.2 Physician Offices
3.1.3 Reference Laboratories
3.1.4 Other End Users
3.2 Global Respiratory Diagnostics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Respiratory Diagnostics Historic Market Size by Application (2018-2023)
3.2.2 Global Respiratory Diagnostics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Respiratory Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Respiratory Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Respiratory Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Respiratory Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Respiratory Diagnostics Revenue Breakdown by Application (2018-2029)
4 Respiratory Diagnostics Competition Analysis by Players
4.1 Global Respiratory Diagnostics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Respiratory Diagnostics as of 2022)
4.3 Date of Key Players Enter into Respiratory Diagnostics Market
4.4 Global Top Players Respiratory Diagnostics Headquarters and Area Served
4.5 Key Players Respiratory Diagnostics Product Solution and Service
4.6 Competitive Status
4.6.1 Respiratory Diagnostics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Philips Healthcare
5.1.1 Philips Healthcare Profile
5.1.2 Philips Healthcare Main Business
5.1.3 Philips Healthcare Respiratory Diagnostics Products, Services and Solutions
5.1.4 Philips Healthcare Respiratory Diagnostics Revenue (US$ Million) & (2018-2023)
5.1.5 Philips Healthcare Recent Developments
5.2 Becton, Dickinson
5.2.1 Becton, Dickinson Profile
5.2.2 Becton, Dickinson Main Business
5.2.3 Becton, Dickinson Respiratory Diagnostics Products, Services and Solutions
5.2.4 Becton, Dickinson Respiratory Diagnostics Revenue (US$ Million) & (2018-2023)
5.2.5 Becton, Dickinson Recent Developments
5.3 Abbott Laboratories
5.3.1 Abbott Laboratories Profile
5.3.2 Abbott Laboratories Main Business
5.3.3 Abbott Laboratories Respiratory Diagnostics Products, Services and Solutions
5.3.4 Abbott Laboratories Respiratory Diagnostics Revenue (US$ Million) & (2018-2023)
5.3.5 Thermo Fisher Scientific Recent Developments
5.4 Thermo Fisher Scientific
5.4.1 Thermo Fisher Scientific Profile
5.4.2 Thermo Fisher Scientific Main Business
5.4.3 Thermo Fisher Scientific Respiratory Diagnostics Products, Services and Solutions
5.4.4 Thermo Fisher Scientific Respiratory Diagnostics Revenue (US$ Million) & (2018-2023)
5.4.5 Thermo Fisher Scientific Recent Developments
5.5 Abbott
5.5.1 Abbott Profile
5.5.2 Abbott Main Business
5.5.3 Abbott Respiratory Diagnostics Products, Services and Solutions
5.5.4 Abbott Respiratory Diagnostics Revenue (US$ Million) & (2018-2023)
5.5.5 Abbott Recent Developments
6 North America
6.1 North America Respiratory Diagnostics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Respiratory Diagnostics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Respiratory Diagnostics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Respiratory Diagnostics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Respiratory Diagnostics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Respiratory Diagnostics Market Dynamics
11.1 Respiratory Diagnostics Industry Trends
11.2 Respiratory Diagnostics Market Drivers
11.3 Respiratory Diagnostics Market Challenges
11.4 Respiratory Diagnostics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
